Max Health And Fortis Over Medanta, Apollo Hospitals — Jefferies Positive On Brownfield Bed Additions

Max Healthcare has the most aggressive expansion plans with bed capacity expansion of more than 50%, while it is more than 30% for Apollo Hospitals, Fortis Health and Medanta.

Jefferies expects strong volume driven-growth in 2025 over average revenue per occupied bed/payor mix optimisation growth. (Photo source: Freepik)

Max Healthcare Institute Ltd. and Fortis Healthcare Ltd. are Jefferies' preferred picks in the hospital space in 2025, as it expects volume driven growth taking precedence and brownfield expansion being a better strategy than greenfield.

"Overall, we continue to expect a sound year for the hospital sector with volume driven growth taking precedence as hospitals add new beds. Our top picks for 2025 are Max and Fortis Healthcare, as both have brownfield bed expansion programs," the firm said in a note.

It projects 20% or higher annualised compounded growth in operating income or Ebitda in three years.

The Case For Max Health And Fortis

Jefferies expects strong volume driven-growth in 2025 over average revenue per occupied bed/payor mix optimisation growth witnessed in past few years, as most of the industry players start to add new beds.

In its coverage, Max Healthcare has the most aggressive expansion plans with bed capacity expansion of more than 50%, while it is more than 30% for Apollo Hospitals Enterprises Ltd., Fortis Health and Global Health Ltd. (Medanta).

The breakeven timelines, margin profile, occupancy and ramp-up of these beds will be key determinant of both the financial as well as stock price performance over the next few years, the note said.

Also Read: Piramal Pharma Is Jefferies' Top Pick Among Contract Manufacturers With Sector Outlook Positive

Hospitals with brownfield expansions are expected to outperform greenfield units in 2025, due to faster breakeven (often within a quarter) and quicker margin accretion. In contrast, greenfield units may face one-three years of operating losses depending on location and size.

Brownfield expansion is the process of redeveloping or expanding existing facilities or infrastructure. Whereas, greenfield development is any kind of development in previously undeveloped plots.

ARPOB growth in fiscal 2026 is likely to moderate to mid-single digits due to new bed additions and potential deterioration in payor mix, as hospitals accommodate lower-tier patients with increased capacity. However, brownfield expansions, with lower incremental costs, are better positioned to offset potential margin pressures, Jefferies said.

Moreover, the growth in foreign medical tourists could be muted in 2025 due to geopolitical challenges across several geographies, the brokerage said. Apollo Hospitals has more sensitivity to medical tourists from Bangladesh, while Delhi NCR-based hospitals have for Middle East and North America.

Share Price Target

  • Apollo Hospitals: 'Buy' rating with target of Rs 8,500 (21% upside over previous close).

  • Fortis Healthcare: 'Buy' rating with target of Rs 860 (25% upside).

  • Max Healthcare: 'Buy' rating with target of Rs 1,380 (20% upside).

  • Medanta: 'Hold' rating with target of Rs 1,170 (9% upside).

Also Read: Midcap Stocks To Continue Outperforming, Says Jefferies, But Advises To Remain Selective

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.
WRITTEN BY
Shubhayan Bhattacharya
Shubhayan covers markets and business news at NDTV Profit. He has a keen in... more
GET REGULAR UPDATES